ChronoDose™ programmable transdermal drug delivery platform
Meets patients' needs
Supports many new drug products
70% of the 45m US Smokers Want to Quit
Current Nicotine Replacement Products:
Do not match craving cycle
Do not provide sufficient nicotine dose
Lead Product - SmartStop™
Nicotine delivered before cravings start, preventing the urge to smoke.
Before Waking Up
The first integrated e-support program for smokers serious about quitting
Communicates wirelessly with mobile devices
Provides informed and constant behavioral support
Measures and helps ensure compliance
The Digital Transdermal Drug Delivery Company
The Science: ChronoDose™
Digital transdermal drug delivery platform
Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support.
CHRONO’s science of specifically tailoring the timing and dose sizes of drugs, preempts predictable peak disease and addiction symptoms with an easy-to-use device.